Moderna weekly uptrend opportunity based On 1.00 Lot Calculation:
- Moderna is a biotechnology company that specializes in mRNA vaccines. Moderna is one of the leading providers of COVID-19 vaccines in the world. Moderna’s Covid-19 vaccine is one of the most effective on the market, and there have been very few negative stories of bad reactions. Some of Moderna’s competitors have not been so fortunate.
- NEWS: Moderna reported its 2nd Quarter Financial Results on August 5th. Its quarterly revenue rose to $4.4 billion compared to only $67 million during the same quarter a year ago. It earned $6.46 per share compared to losing over 35 cents per share for the same quarter last year.
- The United States Food and Drug Administration is now recommending a booster shot for those people who are over 60 and immunocompromised. The U.S., like many other countries, are considering making booster shots standard care for all adults. Booster recommendations increase demand for Moderna’s vaccines.
- Statistics: Only 32.7% of the global population has received one dose of vaccine, and only 24.6% are fully vaccinated. That means there are billions more vaccines that need to be distributed. Moderna has demonstrated its Covid vaccine is one of the most effective in the world, including against the latest Delta variant, and it has been proven effective in young adults 12 to 17.
- NEWS: Moderna was recently added to the S&P 500 Index, making it a must own stock for many passive funds and fund managers that track the index.
- NEWS: The United States Food and Drug Administration just granted full approval to Pfizer’s Covid-19 vaccine. Moderna’s application may be approved in the coming weeks. Moderna filed its initial request for full approval on June 1st. Once given full approval businesses and schools will have more power to mandate customers, employees, and students get vaccinated or be denied entry. Full approval could drive vaccine demand higher.
- Stock Price Action: Moderna’s stock reached an all-time high of $497.49 on August 9, 2021. Its stock currently has 21% upside potential to that price.
(#Moderna), August 24, 2021
Current Price: 410.00
|
Moderna |
Weekly |
|
Trend direction |
|
|
560.00 |
|
|
510.00 |
|
|
460.00 |
|
|
365.00 |
|
|
325.00 |
|
|
295.00 |
Example of calculation base on weekly trend direction for 1.00 Lot*
|
Moderna |
||||||
|
Pivot Points |
||||||
|
Profit or loss in $ |
150,000.00 |
100,000.00 |
50,000.00 |
-45,000.00 |
-85,000.00 |
-115,000.00 |
|
Profit or loss in €** |
127,794.44 |
85,196.29 |
42,598.15 |
-38,338.33 |
-72,416.85 |
-97,975.74 |
|
Profit or loss in £** |
109,310.32 |
72,873.55 |
36,436.77 |
-32,793.10 |
-61,942.52 |
-83,804.58 |
|
Profit or loss in C$** |
189,243.00 |
126,162.00 |
63,081.00 |
-56,772.90 |
-107,237.70 |
-145,086.30 |
* 1.00 lot is equivalent of 1000 units
** Calculations for exchange rate used as of 11:31 (GMT+1) 24/08/2021
Fortrade recommends the use of Stop-Loss and Take-Profit, please speak to your Client Manager regarding their use.
*** You may wish to consider closing your position in profit, even if it is lower than suggested one
**** Trailing stop technique can protect the profit – Ask your Client Manager for more details